23andMe is a genetics and health company founded in 2006 that makes DNA information accessible, understandable and actionable for everyday life. Its direct-to-consumer platform blends ancestry insights with health-related genetic reports through the Health + Ancestry Service, which covers ancestry, health predispositions, carrier status and traits across more than 150 reports, with new features continually added. The company has sold more than 12 million kits.
Technical work spans genomics, consumer genetics, direct-to-consumer genetic testing and health informatics, alongside data de-identification and privacy engineering. Genetic research draws on de-identified, crowdsourced data and is conducted through ethical research partnerships. Health predisposition reports follow regulatory standards and FDA requirements where applicable, and the company works with regulators on safety and accuracy.
23andMe operates with privacy by design embedded in its approach, giving users control of their DNA and data through clear consent choices and transparent communication. It states plainly that its reports are not a clinical diagnosis. The company has been recognised by Time Magazine for shaping the consumer genetics space, and describes accessibility of genetic information and ongoing improvement as standing commitments.
